Aligning mRNA Progress With Regulatory Streamlining - Episode 5

Navigating Challenges and Embracing Opportunities to Optimize mRNA Therapies

Published on: 
, , , ,

Sponsored

The discussion covers the challenges of optimizing mRNA therapies, including the diverse behaviors of mRNA in biological systems, as well as the opportunities presented by emerging mRNA technologies like circular and self-amplifying RNAs, and the role of regulators in ensuring quality control of these novel products.

EP. 1: The Benefits of Working with mRNA for Therapeutics
EP. 2: Public Perception and Communicating the Potential and Safety of mRNA
EP. 3: Lessons from Vaccine Development and Future Possibilities
EP. 4: Streamlining Rare Disease Drug Development
Now Viewing
EP. 5: Navigating Challenges and Embracing Opportunities to Optimize mRNA Therapies
EP. 6: Overcoming Delivery Challenges of mRNA Therapeutics
EP. 7: The Future of Manufacturing, Safety, and Collaboration

The expert panel discussed the diversity of mRNA structures and behaviors, as well as the challenges and opportunities in optimizing mRNA design and synthesis. New directions in mRNA structure and chemistry, such as circular RNAs and self-amplifying RNAs, were also discussed, as well as the increasing complexity of mRNA therapeutics from a regulatory perspective.

Discussion Topics

  • 00:07 - Challenges and opportunities in optimizing mRNA therapies
  • 01:44 - Emerging mRNA technologies
  • 04:20 - Role of regulators